Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling

This publication has 54 references indexed in Scilit:

• Siglecs in innate immunity
  Current Opinion in Pharmacology, 2005
• Expression of caveolin‐1 in lymphocytes induces caveolae formation and recruitment of phosphofructokinase to the plasma membrane
  The FASEB Journal, 2005
• Cell surface sialic acids do not affect primary CD22 interactions with CD45 and surface IgM nor the rate of constitutive CD22 endocytosis
  Glycobiology, 2004
• Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus
  Arthritis & Rheumatism, 2003
• Sialic Acid Binding Domains of CD22 Are Required For Negative Regulation of B Cell Receptor Signaling
  The Journal of Experimental Medicine, 2002
• The Ligand-binding Domain of CD22 Is Needed for Inhibition of the B Cell Receptor Signal, as Demonstrated by a Novel Human CD22-specific Inhibitor Compound
  The Journal of Experimental Medicine, 2002
• Lipid rafts and B-cell activation
  Nature Reviews Immunology, 2002
• Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily
  Current Biology, 1994
• Regulation of lymphocyte activation by the cell-surface molecule CD22
  Immunology Today, 1994
• Association of CD22 with the B cell antigen receptor
  European Journal of Immunology, 1993